Palbociclib After CDK and Endocrine Therapy (PACE)
Palbociclib After CDK and Endocrine Therapy (PACE)
Active, not recruiting · NCT03147287 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Palbociclib After CDK and Endocrine Therapy (PACE) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-09-11 | NCT03147287 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| Pfizer | 431 |
22 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.